General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Sound Group Inc. Issues Letter to Shareholders | globenewswire.com • |
Sound Group Inc. Announces Trading under New Name on Nasdaq | globenewswire.com • |
Sound Group Inc. (Formerly LIZHI INC.) Announces Corporate Name and Ticker Symbol Change | globenewswire.com • |
LIZHI INC. to Change its Nasdaq Ticker Symbol to “SOGP” | globenewswire.com • |
LIZHI INC. to Hold an Extraordinary General Meeting on January 25, 2024 | globenewswire.com • |
LIZHI Announces $3 Million Share Repurchase Program | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-29 | 2023-09 | 0 | N/A | N/A | N/A |
2023-08-29 | 2023-06 | 0 | N/A | N/A | N/A |
2023-05-25 | 2023-03 | 0 | N/A | N/A | N/A |
2023-03-16 | 2022-12 | 0 | N/A | N/A | N/A |
2022-11-16 | 2022-09 | 0 | N/A | N/A | N/A |
2022-08-18 | 2022-06 | 0 | N/A | N/A | N/A |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Acadian Asset Management. LLC | 19.18K | 174.51K | 0.47% |
2023-06-29 | Renaissance Technologies, LLC | 17.36K | 157.98K | 0.43% |
2023-06-29 | Virtu Financial LLC | 5.63K | 51.22K | 0.14% |
2023-06-29 | Susquehanna International Group, LLP | 5.28K | 48.02K | 0.13% |
2023-06-29 | Citadel Advisors Llc | 3.77K | 34.26K | 0.09% |
2023-06-29 | Group One Trading, L.P. | 1.64K | 14.88K | 0.04% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 1.26K | 10.59K | 0.03% |
Split | Date |
---|---|
1 : 10 | 2023-09-20 |
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi
-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.
Lizhi (NASDAQ:LIZI) reported quarterly adjusted earnings of $0.16 per ADS. This is a 100 percent increase over earnings of $0.08 per ADS from the same period last year. The company reported $91.90 million in sales this quarter. This is a 12.75 percent increase over sales of $81.51 million the same period last year.